| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/25/2009 | US20090162893 Alcohol dehydrogenase for the stereoselective production of hydroxy compounds |
| 06/25/2009 | US20090162892 Fermentative production of fine chemicals |
| 06/25/2009 | US20090162884 Method of disulfide crosslink forming in vitro protein synthesis |
| 06/25/2009 | US20090162871 Using solid support comprising immobilized factor VII activating protease (FSAP) to detect autoantibodies against protease; fibrinolysis a nd blood clotting factors |
| 06/25/2009 | US20090162845 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 06/25/2009 | US20090162844 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162391 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | US20090162371 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162366 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/25/2009 | US20090162364 Apo-2 ligand |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162360 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162359 Bivalent, bispecific antibodies |
| 06/25/2009 | US20090162343 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/25/2009 | US20090162341 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | US20090162284 Anti-igf-i receptor antibody |
| 06/25/2009 | CA2709247A1 Improved quality and value of co-products of the ethanol production industry |
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 06/24/2009 | EP1951890A4 Methods and compositions comprising non-natural amino acids |
| 06/24/2009 | EP1861508A4 Cd38 modulated chemotaxis |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | CN100503837C Method for promoting microbial enzyme process to synthesizing glutathione |
| 06/24/2009 | CN100503828C Variable region of monoclonal antibody against HBV s-surface antigen and gene encoding same |
| 06/23/2009 | US7550576 Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor |
| 06/23/2009 | US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
| 06/23/2009 | US7550571 Lafora's disease gene |
| 06/23/2009 | US7550569 Antibodies that specifically bind to GMAD |
| 06/23/2009 | US7550561 Inhibitor of cell cycle progression; cell growth inhibitors; specifically binds a cyclin dependent kinase (cdk); |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550293 Chimeric nicotinic receptor subunits |
| 06/23/2009 | US7550281 Method for production of alpha-amylase in recombinant Bacillus |
| 06/23/2009 | US7550275 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 06/23/2009 | US7550263 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2286395C Production method of heterologous protein |
| 06/23/2009 | CA2226101C Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products |
| 06/23/2009 | CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli |
| 06/23/2009 | CA1341597C Mutant human tissue-type plasminogen activator with a modified carbohydrate structure at amino acid residue 117 |
| 06/18/2009 | WO2009076463A1 Nk-1 receptor mediated delivery of agents to cells |
| 06/18/2009 | WO2009075376A1 Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 06/18/2009 | WO2009075329A1 Gelatin composition with controlled degradability |
| 06/18/2009 | WO2009073977A1 Polypeptides modified by protein trans-splicing technology |
| 06/18/2009 | WO2009073975A1 Production of recombinant interferon proteins |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | WO2003072756A3 Cloning and characterization of slc26a8 and slc26a11 anion exchangers |
| 06/18/2009 | WO2003060153A3 Irak-m is a negative regulator of toll-like receptor signaling |
| 06/18/2009 | WO2003000909A3 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 06/18/2009 | US20090158470 Compositions and methods for the treatment of Pierce's Disease |
| 06/18/2009 | US20090158460 Plant Diacylglycerol Acyltransferases |
| 06/18/2009 | US20090156785 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease |
| 06/18/2009 | US20090156534 Globin lentiviral vectors for treatment of disease |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156472 Cyclic Depsipeptides |
| 06/18/2009 | US20090156457 Methods and means for screening for rhomboid activity |
| 06/18/2009 | US20090156427 Bio-Sensing Nanodevice |
| 06/18/2009 | US20090155930 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155888 Fluorescent protein |
| 06/18/2009 | US20090155850 Horse:Human Chimeric Antibodies |
| 06/18/2009 | US20090155849 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters |
| 06/18/2009 | US20090155848 Derived from filamentous fungus belonging to genus Penicillium; improved heat resistance and substrate specificity |
| 06/18/2009 | US20090155847 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
| 06/18/2009 | US20090155846 Kinase anchor protein muteins, peptides thereof and related methods |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155844 METHOD OF SYNTHESIZING A SUPPRESSOR tRNA, DNA CONSTRUCT AND USE THEREOF FOR PRODUCING A NON-NATURAL AMINO ACID-INCORPORATED PROTEIN |
| 06/18/2009 | US20090155843 Tnf antagonists |
| 06/18/2009 | US20090155824 Methods for antibody engineering |
| 06/18/2009 | US20090155810 Methods for producing members of specific binding pairs |
| 06/18/2009 | US20090155797 Methods For Generating Enhanced Antibody-Producing Cell Lines With Improved Growth Characteristics |
| 06/18/2009 | US20090155775 Cloned dna polymerases from thermotoga and mutants thereof |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155304 Modified Cyanovirin-N Polypeptide |
| 06/18/2009 | US20090155283 Noncompetitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 |
| 06/18/2009 | US20090155271 pro-inflammatory cytokines, interleukins (IL-17A, IL-17F) |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155258 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 06/18/2009 | US20090155257 Immunoglobulin variants and uses thereof |
| 06/18/2009 | US20090155255 Cd23 binding molecules and methods of use thereof |
| 06/18/2009 | US20090155251 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/18/2009 | US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 06/18/2009 | US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them |
| 06/18/2009 | US20090155231 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery |
| 06/18/2009 | US20090155213 Lactobacillus acidophilus nucleic acids and uses thereof |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155165 Anti-igf-i receptor antibody |
| 06/18/2009 | US20090155164 Human c-fms antigen binding proteins |
| 06/18/2009 | US20090152196 Altering metabolism in biological processes |
| 06/18/2009 | US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives |
| 06/18/2009 | CA2707979A1 Polypeptides modified by protein trans-splicing technology |
| 06/18/2009 | CA2703079A1 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome |